‘The Untreatable are Treatable’: Autism Summit 2026 Opens with Shift Towards Biology

SAN DIEGO (April 25, 2026) — The Autism Health Summit opened this week with a clear message: the conversation around autism is changing.

Held at the Legacy Center, an educational complex often referred to as the “Bible-based Disneyland”; parents, doctors and researchers gathered under a large immersive display. The tone was different from last year. The focus was no longer just awareness. It was biology.

In 2025, Prof. Dato’ Sri Dr. Mike K. S. Chan met autism advocate Tracy Slepcevic, known as “Warrior Mom,” a moment that reflected growing momentum from parents worldwide. That same year, autism also drew political attention with Robert F. Kennedy Jr. calling for answers and possible breakthroughs by September 2025.

A year later, Chan returned with a more direct message against this backdrop.

From Behavior to Biology

“The untreatable are treatable,” Chan told delegates.

“But only when we understand the body — not just behavior, but biology.”

Prof. Mike Chan, founder of European Wellness Biomedical Group, said autism must be seen as a multisystem condition.

“Autism is not only a brain issue,” he said.
“It involves the gut, the immune system, inflammation, toxins and mitochondria.”

He said symptoms should not be viewed in isolation. Instead, they must be linked to underlying biological processes.

A Summit Evolving

The three-day summit, held from April 24 to 26, brought together global experts. Speakers covered medicine, neuroscience, nutrition and advocacy.

This year’s program included sessions on regenerative medicine, peptides and neurodevelopment. Clinical discussions focused on gut health, immune balance, detoxification and metabolism. Parents also shared their experiences.

Compared with 2025, the tone was more clinical. The emphasis was on science and treatment frameworks.

“Last year we talked about voices,” Prof. Mike Chan said. “This year we must go deeper.”

Precision Over Generalization

Chan stressed that autism care must be personalized.

“You cannot treat every child the same way,” he said. “Each child has a different biological picture.”

He warned against oversimplifying new therapies.

“We must stop generalizing,” he said.
“One solution cannot treat everything.”

He repeated his principle of specificity.

“A1 must treat A1. B6 must treat B6. Z10 must treat Z10,” he said. “This is precision medicine.”

Setting the Direction

As the summit began, one theme stood out. Autism care is moving toward deeper biological understanding.

For Chan, the path forward is clear.

“The future is precision,” he said. “We must understand the body at the cellular level and give the right support at the right time.”

With two days remaining, the summit set a new tone — one that looks beyond labels and toward measurable, biology-based care.